MedPath

Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis

Phase 4
Completed
Conditions
Gingivitis
Interventions
Drug: Stannous Fluoride Toothpaste
Drug: Colgate fluoride toothpaste
Registration Number
NCT05731778
Lead Sponsor
Colgate Palmolive
Brief Summary

Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.

Detailed Description

A 9-weeks clinical study will be conducted to evaluate a stannous fluoride dentifrice for therapeutic effects that aim to delay the onset of experimental gingivitis as well as hasten the resolution of disease.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  1. Male or female volunteers aged 18-70 years
  2. In good general health, ASA I
  3. No clinical signs of gingival inflammation at >90% sites observed
  4. Probing Depth (PD) < 3.0 mm
  5. Attachment Loss (AL) = 0 mm
  6. No periodontal disease history
  7. Non-smokers
  8. Fluent in English
Exclusion Criteria
  1. Presence of orthodontic bands.
  2. Presence of partial removal dentures.
  3. Tumour(s) of the soft or the hard tissues of the oral cavity.
  4. Cavitated carious lesions requiring immediate restorative treatment.
  5. History of allergy to consumer or personal care products or dentifrice ingredients as determined by the dental profession monitoring the study.
  6. Participation in any other clinical study or test panel with a one month period prior to entering the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stannous fluoride test toothpasteStannous Fluoride ToothpasteCurrently marketed as the new Colgate Total SF containing Stannous Fluoride
Colgate flouride toothpasteColgate fluoride toothpasteColgate Dental Cream containing Stannous Sodium Fluoride
Primary Outcome Measures
NameTimeMethod
Bleeding Index (BOP) and Oral Inflammatory Loadduring patient visit over the 9 weeks

BOP is a bleeding index standard in field, oral inflammatory load as measured by neutrophil levels in oral rinses

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Toronto

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath